| scholarly article | Q13442814 |
| P356 | DOI | 10.3899/JRHEUM.130738 |
| P698 | PubMed publication ID | 24737913 |
| P50 | author | Peter Tugwell | Q28036951 |
| Claire Bombardier | Q28322236 | ||
| P2093 | author name string | G. A. Wells | |
| B. Shea | |||
| E. T. Ghogomu | |||
| M. V. Swinden | |||
| T. Rader | |||
| W. Katchamart | |||
| Z. Ortiz | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| methotrexate | Q422232 | ||
| folic acid | Q127060 | ||
| P304 | page(s) | 1049-1060 | |
| P577 | publication date | 2014-04-15 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Folic Acid and Folinic Acid for Reducing Side Effects in Patients Receiving Methotrexate for Rheumatoid Arthritis | |
| P478 | volume | 41 |
| Q38375128 | A systematic review of community pharmacist therapeutic knowledge of dietary supplements. |
| Q89745202 | Adverse Effects of Low-Dose Methotrexate: A Randomized Trial |
| Q30277969 | Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review |
| Q90030504 | Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials |
| Q52640450 | Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines. |
| Q37748005 | Drug-induced liver injury: Do we know everything? |
| Q26768270 | Elderly patients and inflammatory bowel disease |
| Q45815712 | Guidelines for the management of atopic dermatitis (eczema) for pharmacists |
| Q47961270 | Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches |
| Q38419578 | Inflammatory bowel disease and the elderly: a review |
| Q38368489 | Leveraging the electronic health record to improve quality and safety in rheumatology. |
| Q38801158 | MISS questionnaire in French version: a good tool for children and parents to assess methotrexate intolerance |
| Q64939479 | Magnesium and Drugs. |
| Q61813381 | Main Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases |
| Q47317459 | Maternal and postweaning folic acid supplementation interact to influence body weight, insulin resistance, and food intake regulatory gene expression in rat offspring in a sex-specific manner |
| Q55617607 | Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. |
| Q50053714 | Nicotinamide Phosphoribosyltransferase Deficiency Potentiates the Anti-proliferative Activity of Methotrexate through Enhanced Depletion of Intracellular ATP. |
| Q38691711 | Palliative low dose fortnightly methotrexate in oral cancer |
| Q40041428 | Psoriatic flare after the concomitant administration of L-methylfolate and methotrexate |
| Q92310083 | Recent advances in understanding and managing pediatric inflammatory bowel disease |
| Q94525709 | Refractory Sarcoidosis: A Review |
| Q49680083 | Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study. |
| Q55055261 | Severe Harm and Death Associated With Errors and Drug Interactions Involving Low-Dose Methotrexate. |
| Q55710750 | Simultaneous Binding of Folic Acid and Methotrexate to Human Serum Albumin: Insights into the Structural Changes of Protein and the Location and Competitive Displacement of Drugs. |
| Q36027291 | Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. |
| Q42695266 | Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told? |
Search more.